Kamel Khalili Email

Chief Scientific Founder . Excision BioTherapeutics

Current Roles

Employees:
59
Revenue:
$9.1M
About
Excision BioTherapeutics is a private company focused on developing advanced gene editing therapeutics to address the medical need for the treatment of life-threatening disease caused by viral infections. Our mission is to advance gene editing therapeutics for our indications into safe and efficacious medicines that will greatly improve the lives of infected individuals around the world.
Excision BioTherapeutics Address
499 Jackson Street
Philadelphia, PA
United States
Excision BioTherapeutics Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.